Method of using melanocyte stimulating hormone as dermatis treat

Details Method of using melanocyte stimulating hormone as dermatis treat Method of using melanocyte stimulating hormone as dermatis treat

1989-03-13

1989-10-17

Lee, Lester L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 14, A61K 3702, C07K 708

Patent

active

048747440

ABSTRACT:
Dermatitis is treated by topically applying a composition including melanocyte stimulating hormone to the epidermal portion of the infected skin. Preferably, alpha-melanocyte stimulating hormone is applied in a concentration in the range of about 5.times.10.sup.-5 M/cm.sup.2. This is an effective treatment against a broad range of dermatitis. Occlusion of the affected site enhances response.

REFERENCES:
patent: 4444762 (1984-04-01), Rajadhyasksha
patent: 4593038 (1986-06-01), Burzynski
patent: 4755535 (1988-07-01), Minaskanian et al.
Rheins et al: The Journal of Immunology, vol. 136, No. 3, Feb. 1, 1986.
Rheins et al: Cellular Immunology 106, 33-42 (1987).
Robertson et al: Inflammation, vol. 10, No. 4, 1986.
Ali et al: Abstracts, vol. 87, No. 3, 9/86, p. 413.
Cannon et al: Journal of Immunology, vol. 137, 2232-2236, No. 7, Oct. 1, 1986.

Affiliated with

Also associated with

Rating

Method of using melanocyte stimulating hormone as dermatis treat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of using melanocyte stimulating hormone as dermatis treat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using melanocyte stimulating hormone as dermatis treat will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1743608